ATE278710T1 - Antimikrobiell wirksame peptide - Google Patents

Antimikrobiell wirksame peptide

Info

Publication number
ATE278710T1
ATE278710T1 AT99902926T AT99902926T ATE278710T1 AT E278710 T1 ATE278710 T1 AT E278710T1 AT 99902926 T AT99902926 T AT 99902926T AT 99902926 T AT99902926 T AT 99902926T AT E278710 T1 ATE278710 T1 AT E278710T1
Authority
AT
Austria
Prior art keywords
amino acids
domain
antimicrobial peptides
majority
peptides
Prior art date
Application number
AT99902926T
Other languages
English (en)
Inventor
Nieuw Amerongen Arie Van
Engelmundus Cornelis I Veerman
T Hof Willem Van
Eva Josephine Helmerhorst
Original Assignee
Barnaux Healthcare B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barnaux Healthcare B V filed Critical Barnaux Healthcare B V
Application granted granted Critical
Publication of ATE278710T1 publication Critical patent/ATE278710T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT99902926T 1998-01-27 1999-01-26 Antimikrobiell wirksame peptide ATE278710T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1008139A NL1008139C2 (nl) 1998-01-27 1998-01-27 Antimicrobiële peptiden.
PCT/NL1999/000045 WO1999037678A2 (en) 1998-01-27 1999-01-26 Antimicrobial peptides

Publications (1)

Publication Number Publication Date
ATE278710T1 true ATE278710T1 (de) 2004-10-15

Family

ID=19766423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902926T ATE278710T1 (de) 1998-01-27 1999-01-26 Antimikrobiell wirksame peptide

Country Status (10)

Country Link
US (1) US6638531B1 (de)
EP (1) EP1051433B1 (de)
JP (1) JP2003524578A (de)
AT (1) ATE278710T1 (de)
AU (1) AU759026B2 (de)
CA (1) CA2319094C (de)
DE (1) DE69920877T2 (de)
ES (1) ES2229669T3 (de)
NL (1) NL1008139C2 (de)
WO (1) WO1999037678A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69903732T2 (de) * 1998-07-02 2003-07-03 Stichting Skeletal Tissue Engineering Group Amsterdam, Amsterdam Knochenzement mit antimikrobiellen peptiden
NL1010692C2 (nl) * 1998-12-01 2000-06-06 Stichting Tech Wetenschapp Antivirale peptiden.
EP1174027A1 (de) * 2000-07-17 2002-01-23 HOM Consultancy B.V. Verwendungen antimikrobieller Peptide
US7550558B2 (en) * 2001-06-01 2009-06-23 Fundacao De Ampara A Pesquiso Do Estado De Sao Paolo (Fapesp) Antimicrobial peptides and methods for identifying and using such peptides
WO2005019241A2 (en) * 2003-08-18 2005-03-03 E.I. Dupont De Nemours And Company Cationic antimicrobial peptides and compositions thereof
JP2005350424A (ja) * 2004-06-14 2005-12-22 Kyocera Chemical Corp 固形製剤および固形製剤の製造方法
WO2013039861A2 (en) 2011-09-12 2013-03-21 modeRNA Therapeutics Engineered nucleic acids and methods of use thereof
CN104411338A (zh) 2012-04-02 2015-03-11 现代治疗公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
WO2013151665A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
US8963676B1 (en) * 2013-03-12 2015-02-24 XP Power Limited Configurable transformer module
WO2014144004A1 (en) 2013-03-15 2014-09-18 The Board Of Trustees Of The University Of Arkansas Peptides with antifungal activity and methods of using the peptides
US10457710B2 (en) 2015-06-30 2019-10-29 Chain Antimicrobials Oy Antimicrobial peptides, their variants and uses
WO2017001732A1 (en) 2015-06-30 2017-01-05 Oulun Yliopisto New antimicrobial peptides, their variants and uses
ES2808780T3 (es) 2015-06-30 2021-03-01 Chain Antimicrobials Oy Nuevos péptidos antimicrobianos, sus variantes y usos
WO2017083515A2 (en) 2015-11-10 2017-05-18 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
JP6658265B2 (ja) * 2016-04-26 2020-03-04 ライオン株式会社 インビトロバイオフィルムモデルの製造方法、ならびに評価方法及び口腔用組成物を選定する方法
JP7303110B2 (ja) 2017-01-18 2023-07-04 ビステラ， インコーポレイテッド 抗体分子－薬物コンジュゲートおよびその使用
US11338020B2 (en) 2018-01-09 2022-05-24 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
ES3032290T3 (en) 2018-03-20 2025-07-16 Theriva Biologics Inc Intestinal alkaline phosphatase formulations
US11654184B2 (en) 2018-03-20 2023-05-23 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
JP7660523B2 (ja) 2019-05-06 2025-04-11 セリバ・バイオロジクス・インコーポレイテッド アルカリリン酸塩に基づいた癌治療
KR20240085798A (ko) 2020-04-03 2024-06-17 비스테라, 인크. 항체 분자-약물 접합체 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
US5294605A (en) * 1990-07-19 1994-03-15 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
AU674525B2 (en) * 1992-06-01 1997-01-02 Magainin Pharmaceuticals, Inc. Biologically active peptides having N-terminal substitutions
US6579696B1 (en) * 1992-12-21 2003-06-17 Promega Corporation Polymyxin B conjugates
AU3512595A (en) * 1994-09-13 1996-03-29 Magainin Pharmaceuticals, Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds

Also Published As

Publication number Publication date
WO1999037678A3 (en) 1999-10-14
WO1999037678A2 (en) 1999-07-29
CA2319094A1 (en) 1999-07-29
JP2003524578A (ja) 2003-08-19
EP1051433A2 (de) 2000-11-15
AU2301499A (en) 1999-08-09
CA2319094C (en) 2009-03-17
EP1051433B1 (de) 2004-10-06
US6638531B1 (en) 2003-10-28
ES2229669T3 (es) 2005-04-16
NL1008139C2 (nl) 1999-07-28
AU759026B2 (en) 2003-04-03
DE69920877D1 (de) 2004-11-11
DE69920877T2 (de) 2005-02-03

Similar Documents

Publication Publication Date Title
ATE278710T1 (de) Antimikrobiell wirksame peptide
PT788509E (pt) Derivados peptidicos terapeuticos
ATE462006T1 (de) Isoform des vegfs
EE03693B1 (et) Isoleeritud dimeerne fibroblastide aktivatsioonivalk alfa ja selle kasutusalad
UA32523C2 (uk) Пептиди, які мають високу біологічну активність, та фармацевтична композиція на їх основі
NO960939D0 (no) Kininogenaseinhibitor
TR200002101T2 (tr) Dondurulmuş gıda ürünü.
ATE110742T1 (de) Peptid-verbindungen.
WO1999000407A3 (en) Improved bacillus thuringiensis toxin
BR9711540A (pt) Inibidores de protease proteìnico estabilizados e variantes dos mesmos
TR199600583A2 (tr) Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi.
ATE362769T1 (de) Lineare kationische peptide mit fungizider wirksamkeit
ATE238791T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
SE9700301D0 (sv) New compound
DE50015133D1 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
IT1277057B1 (it) Peptidi antigenici migliorati

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties